[sun-shine]

Dapagliflozin;
cas#461432-26-8;
purity>98 , %;
in stock!
www.sun-shinechem.com
sales@sun-shinechem.com


Dapagliflozin (rINN/USAN)is an experimental drug being studied by Bristol-Myers Squibb in partnership with AstraZeneca as a potential treatment for type 1[1] and 2 diabetes. Although dapagliflozin's method of action would operate on either type of diabetes or other conditions resulting in hyperglycemia, the current clinical trials specifically exclude participants with Type 1 diabetes